158 related articles for article (PubMed ID: 37928269)
21. Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma.
Guan Y; Song H; Zhang G; Ai X
Oncol Rep; 2014 Aug; 32(2):748-54. PubMed ID: 24890092
[TBL] [Abstract][Full Text] [Related]
22. EIF4A3 Acts on the PI3K-AKT-ERK1/2-P70S6K Pathway through FLOT1 to Influence the Development of Lung Adenocarcinoma.
Yu W; Liang J; Fang T; Jiang J; Zhao R; Li R; Han J; Tian H
Mol Cancer Res; 2023 Jul; 21(7):713-725. PubMed ID: 37011005
[TBL] [Abstract][Full Text] [Related]
23. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
Kumbrink J; Kirsch KH
Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
[TBL] [Abstract][Full Text] [Related]
24. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
Howlin J; Rosenkvist J; Andersson T
Breast Cancer Res; 2008; 10(2):R36. PubMed ID: 18435854
[TBL] [Abstract][Full Text] [Related]
25. Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1.
Chen K; Wu Q; Hu K; Yang C; Wu X; Cheung P; Williams KJ
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):102-113. PubMed ID: 29162604
[TBL] [Abstract][Full Text] [Related]
26. Flotillin-1 enhances radioresistance through reducing radiation-induced DNA damage and promoting immune escape via STING signaling pathway in non-small cell lung cancer.
Wang Y; Meng L; Meng S; Huang L; Luo S; Wu X; Gong X
Cancer Biol Ther; 2023 Dec; 24(1):2203332. PubMed ID: 37131290
[TBL] [Abstract][Full Text] [Related]
27. The roles of FLOT1 in human diseases (Review).
Zhan Z; Ye M; Jin X
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37772385
[TBL] [Abstract][Full Text] [Related]
28. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
Wang Y; Lazo JS
Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
[TBL] [Abstract][Full Text] [Related]
29. Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.
Waters AM; Khatib TO; Papke B; Goodwin CM; Hobbs GA; Diehl JN; Yang R; Edwards AC; Walsh KH; Sulahian R; McFarland JM; Kapner KS; Gilbert TSK; Stalnecker CA; Javaid S; Barkovskaya A; Grover KR; Hibshman PS; Blake DR; Schaefer A; Nowak KM; Klomp JE; Hayes TK; Kassner M; Tang N; Tanaseichuk O; Chen K; Zhou Y; Kalkat M; Herring LE; Graves LM; Penn LZ; Yin HH; Aguirre AJ; Hahn WC; Cox AD; Der CJ
Cell Rep; 2021 Jun; 35(13):109291. PubMed ID: 34192548
[TBL] [Abstract][Full Text] [Related]
30. The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
Brinkman A; de Jong D; Tuinman S; Azaouagh N; van Agthoven T; Dorssers LC
Breast Cancer Res Treat; 2010 Apr; 120(2):401-8. PubMed ID: 19412734
[TBL] [Abstract][Full Text] [Related]
31. Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
Zhang Y; Huang P; Liu X; Xiang Y; Zhang T; Wu Y; Xu J; Sun Z; Zhen W; Zhang L; Si Y; Liu Y
J Pharmacol Sci; 2018 Jul; 137(3):305-312. PubMed ID: 30119963
[TBL] [Abstract][Full Text] [Related]
32. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
Deng B; Sun Z; Jason W; Yang P
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
[TBL] [Abstract][Full Text] [Related]
33. FAM201A Promotes Cervical Cancer Progression and Metastasis through miR-1271-5p/Flotillin-1 Axis Targeting-Induced Wnt/
Wang Y; Wang Z; Cheng K; Hao Q
J Oncol; 2022; 2022():1123839. PubMed ID: 36226250
[TBL] [Abstract][Full Text] [Related]
34. FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis.
Mao S; Qian Y; Wei W; Lin X; Ling Q; Ye W; Li F; Pan J; Zhou Y; Zhao Y; Huang X; Huang J; Hu C; Li M; Sun J; Jin J
Ann Hematol; 2023 Mar; 102(3):583-595. PubMed ID: 36697954
[TBL] [Abstract][Full Text] [Related]
35. Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids.
Konstantinovsky S; Davidson B; Reich R
Clin Exp Metastasis; 2012 Aug; 29(6):527-40. PubMed ID: 22476538
[TBL] [Abstract][Full Text] [Related]
36. MiR-1294 acts as a tumor inhibitor in cervical cancer by regulating FLOT1 expression.
Kan XQ; Li YB; He B; Cheng S; Wei Y; Sun J
J Biol Regul Homeost Agents; 2020 Apr; 34(2):. PubMed ID: 32329296
[TBL] [Abstract][Full Text] [Related]
37. PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion.
Wang G; Zhang Q; Song Y; Wang X; Guo Q; Zhang J; Li J; Han Y; Miao Z; Li F
Cell Death Dis; 2015 Mar; 6(3):e1682. PubMed ID: 25766321
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of microRNA‑27b contributes to the migration and invasion of gastric cancer cells via the inhibition of sprouty2‑mediated ERK signaling.
Jiang J; Yi B; Qin C; Ding S; Cao W
Mol Med Rep; 2016 Mar; 13(3):2267-72. PubMed ID: 26781754
[TBL] [Abstract][Full Text] [Related]
39. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Jiang S; Mao C; Jiang B; Tan Q; Deng B
Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA‑485‑5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin‑1 and inhibits the epithelial‑mesenchymal transition.
Zhao R; Shan Y; Zhou X; Zhang C; Zhao R; Zhao L; Shan B
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
